Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Online-Ressource
    Online-Ressource
    Wiley ; 2013
    In:  Journal of Evaluation in Clinical Practice Vol. 19, No. 4 ( 2013-08), p. 697-702
    In: Journal of Evaluation in Clinical Practice, Wiley, Vol. 19, No. 4 ( 2013-08), p. 697-702
    Kurzfassung: Like health technology assessment ( HTA ) agencies, hospitals are faced with requests for innovative and costly medical devices. However, local decision makers are frequently confronted with a lack of high‐quality clinical data when assessing the effectiveness of innovative medical devices. The aim of this study was to quantify the level of evidence available for innovative medical devices in the context of hospital‐based HTA . Methods We searched the M edline, E mbase and C ochrane L ibrary databases for articles, letters and reports relating to 32 innovative medical devices requested at our hospital between J anuary 2008 and M arch 2012. All clinical studies retrieved were screened and classified according to the S ackett 5‐point level‐of‐evidence scale. Results We screened and classified 217 studies: 215 clinical trials and 2 cost‐effectiveness studies. Only 47 of the 215 clinical studies (22%) provided high‐level clinical evidence (levels 1–2); 33 (15%) were randomized controlled trials ( RCT s). More than half of the 215 studies (52.1%) included fewer than 30 patients. Only 14 of the 47 high‐quality studies reported the amount of missing data. For implantable medical devices, 84 (71.8%) studies specified the follow‐up period and the mean follow‐up period was 18.9 months. Finally, methodological quality did not increase with the risk level of the medical device. Conclusions Our findings confirm that only a few studies of innovative medical devices provide high‐level clinical evidence. Nevertheless, RCT may be the ‘gold standard’ for drugs, but it is not always appropriate for medical devices. Changes to the European regulation of medical devices, with the requirement for a demonstration of clinical efficacy and safety before release onto the European market, have raised expectations.
    Materialart: Online-Ressource
    ISSN: 1356-1294 , 1365-2753
    URL: Issue
    Sprache: Englisch
    Verlag: Wiley
    Publikationsdatum: 2013
    ZDB Id: 2006772-0
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz